Radomlje, Slovenia

Slavko Pecar

This inventor holds 1 USPTO granted patent. Top assignees: Lek Pharmaceuticals D.d., University of Ljubljana, Faculty of Pharmacy. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Slavko Pecar. Retrieved from https://idiyas.com/inventor/slavko-pecar-2c5ebu7e

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Slavko Pecar

Introduction

Slavko Pecar is a notable inventor based in Radomlje, Slovenia. He has made significant contributions to the field of pharmaceuticals, particularly in the development of thrombin inhibitors. His work has implications for various medical applications, showcasing his expertise and dedication to innovation.

Latest Patents

Slavko Pecar holds a patent for novel thrombin inhibitors, which are described by the formula I and pharmaceutically acceptable salts thereof. The compounds he developed are useful as thrombin inhibitors, providing potential therapeutic benefits in treating conditions related to thrombin activity. He has 1 patent to his name, reflecting his innovative contributions to the field.

Career Highlights

Throughout his career, Slavko has worked with esteemed institutions such as the University of Ljubljana, Faculty of Pharmacy, and Lek Pharmaceuticals D.d. His experience in these organizations has allowed him to collaborate with leading professionals in the pharmaceutical industry, further enhancing his expertise.

Collaborations

Some of his notable coworkers include Lucija Peterlin Marsic and Danijel Kikelj. Their collaborative efforts have contributed to the advancement of research and development in the pharmaceutical sector.

Conclusion

Slavko Pecar's work in developing thrombin inhibitors exemplifies his commitment to innovation in pharmaceuticals. His contributions are significant in advancing medical science and improving patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…